Viatris (VTRS)
(Delayed Data from NSDQ)
$8.98 USD
+0.04 (0.45%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $8.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Viatris Inc. has a PEG ratio of 0.52 compared to the Medical Services industry's PEG ratio of 1.63.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
VTRS 8.98 +0.04(0.45%)
Will VTRS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VTRS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VTRS
Viatris Poised to Report Q2 Earnings: What's in Store for the Stock?
VTRS Down on Late-Stage Study Failure of Eye Disease Drug
VTRS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris
3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff Threats
TBPH to Sell Remaining Trelegy Royalty Interest to GSK, Stock Rises
Other News for VTRS
Viatris Inc. (VTRS) Announces New Board Appointment
Viatris Announces Appointment of David Simmons to the Company's Board of Directors | VTRS Stock News
Viatris Announces Quarterly Dividend | VTRS Stock News
Viatris declares $0.12 dividend
Earnings Scorecard: 18 out of 21 healthcare firms beat earnings forecast this week